Fundz

Neumentum, Inc. reported raising $16.6 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEOct 14, 2021$16.6M of $20M raised

Amount Raised

$16.6 Million

$16.6 Million sold, per SEC Form D (first sale Oct 14, 2021)

Round Type

Venture

SummitHealthcare

Quick answer

Neumentum, Inc. raised $16.6 Million in a funding round, dated October 14, 2021. Neumentum, Inc. is based in Summit, New Jersey, United States.

How much did Neumentum, Inc. raise?
Neumentum, Inc. raised $16.6 Million in a funding round on October 14, 2021.
What does Neumentum, Inc. do?
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world.
Where is Neumentum, Inc. based and how big is it?
Neumentum, Inc. is based in Summit, New Jersey, United States.
Who are the decision-makers at Neumentum, Inc?
Fundz holds 1 contact at Neumentum, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Neumentum, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Mitesco raised $3.1M (Seed) on November 26, 2021.
  • Flexwise Health, Inc. raised $1.3M (Seed) on November 24, 2021.
  • UE LifeSciences Inc. raised $480K (Seed) on November 24, 2021.
  • TECKRO, INC. raised $25M on November 24, 2021.
  • SEELOS THERAPEUTICS, INC. raised $20M (Convertible Note) on November 24, 2021.
  • TruTag Technologies, Inc. raised $15M on November 24, 2021.

Who to call at Neumentum, Inc., and when

A new round usually means Neumentum, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neumentum, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neumentum, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neumentum, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neumentum, Inc.

Location

350 SPRINGFIELD AVENUE

Summit, New Jersey, United States

About

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse, and diversion seen with opioids, or the opioid-induced side effects, including potentially life-threatening respiratory depression. Neumentum has two lead product candidates being developed to directly help address the opioid crisis. NTM-001, currently in Phase 3, is an IV formulation of Toradol (ketorolac) with Phase I results showing that it may provide consistent, steady blood plasma levels of ketorolac over 24 hours and durable analgesic effect. NTM-001 has the potential to be the first-ever NSAID approved for continuous infusion. NTM-006, a Phase 2 novel oral analgesic with a target indication for acute and chronic pain that has demonstrated meaningful analgesia in a Phase 2a Proof of Concept study, was licensed from Janssen Pharmaceuticals NV and McNeil Consumer Pharmaceuticals Co., both part of the Johnson & Johnson Family of Companies. Neumentum is led by an executive team of biotech and pharmaceutical experts who have extensive experience in pain and neurology, from drug development through commercialization. For more information, visit www.Neumentum.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neumentum, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTaggart M., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Neumentum, Inc.'s next move

See what Strategic adds

Neumentum, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.